選單 研討會快訊 最新醫療快訊 藥物安全警訊 學會行事曆 Long-Term Reassurance and Practical Management of Continuous BTK Inhibition in CLL Featured Video 2026-03-12 查看更多 A Radiation Oncology Recap Updates in Radiation Oncology 2026-03-12 查看更多 Setting the Stage: The Rise of BCMA Bispecific Antibodies in Myeloma Featured Video 2026-03-10 查看更多 FDA Grants Approval to Teclistamab Combo in RRMM The Commissioner’s National Priority Voucher has been granted by the FDA to teclistamab plus daratumumab hyaluronidase-fihj in relapsed/refractory multiple myeloma. 2026-03-06 查看更多 FDA Gives Tentative GEP-NETs Approval FDA Grants Tentative Approval to PNT2003 for GEP-NETs Rusfertide Earns FDA Priority Review in Polycythemia Vera Videos Trending 2026-03-05 查看更多 Practical Implementation of Oral HMAs in MDS/CMML: Safety, Monitoring, and Coordination Featured Video 2026-03-05 查看更多 Relacorilant Regimen Boosts Survival in PROC Relacorilant Plus Nab-Paclitaxel Significantly Improves Survival in PROC Top 5 Takeaways on Advances in Rare Melanoma Management NEW VIDEO Videos Trending 2026-03-03 查看更多 CancerNetwork® at ASCO GU 2026 Updates at ASCO GU 2026Enfortumab Vedotin Combo Boosts MIBC Survival Outcomes in EV-304 Trial Data Show Comparable Immunotherapy Outcomes Across RCC Age Populations Examining Pembrolizumab Combo Safety in High-Risk Prostate Cancer Cabazitaxel Combo Does Not Significantly Improve Prostate Cancer Survival 2026-03-03 查看更多 1234
